DePuy (J&J)’s Teligen System Receives the US FDA Approval for User-Centric Procedural Control During Spine Surgery
Shots:
- The approval was based on a study evaluating Teligen System in cadavers (n=6) to detect its suitability as an MIS-TLIF procedure with results demonstrating a reduction in fluoroscopy time (47%) vs surgical microscope-aided MIS-TLIF procedures along with a reduction in instrument trays & processing costs per surgery
- The system comprises of a camera control system, a VueLIF-T Procedure Kit with a disposable HD camera, a Teligen Clear Discectomy Device & patient-based disposable ports. The system is integrated with Unleash bundle of implant solutions designed to streamline the main stages of MIS-TLIF
- Teligen System provides an unobstructed view of the surgical site, hands-free visualization during the procedure, a multidirectional & expanded field view
Ref: PR Newswire | Image: PR Newswire
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
